Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guangdong Marubi Biotechnology CoSHSE:603983 +6.71%87 Return-on-Tangible-Equity is 13.52% as of Mar. 2026, which is 8% below its 10-year median of 14.71. GuruFocus rates SHSE:603983 with a GF Score™ of 87/100 and a GF Value™ of ¥43.76 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,882 Consumer Packaged Goods companies, Guangdong Marubi Biotechnology Co ranks worse than 51.54% on this metric.
The historical rank and industry rank for Guangdong Marubi Biotechnology Co's Return-on-Tangible-Equity or its related term are showing as below:
SHSE:603983'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 7.32 Med: 14.71 Max: 36.27
Current: 7.56
During the past 13 years, Guangdong Marubi Biotechnology Co's highest Return-on-Tangible-Equity was 36.27%. The lowest was 7.32%. And the median was 14.71%.
SHSE:603983's Return-on-Tangible-Equity is ranked worse than 51.54% of 1882
companies
in the Consumer Packaged Goods industry
Industry Median: 8.05
vs SHSE:603983: 7.56
Guangdong Marubi Biotechnology Co (SHSE:603983) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Guangdong Marubi Biotechnology Co Return-on-Tangible-Equity Related Terms
Guangdong Marubi Biotechnology Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Marubi Biotechnology Co Return-on-Tangible-Equity Chart
SHSE:603983 vs PG, CL, KVUE: Return-on-Tangible-Equity Comparison
For the Household & Personal Products subindustry, Guangdong Marubi Biotechnology Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Marubi Biotechnology Co Return-on-Tangible-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Guangdong Marubi Biotechnology Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Guangdong Marubi Biotechnology Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 13.52% mean?
Guangdong Marubi Biotechnology Co (SHSE:603983) has a Return-on-Tangible-Equity of 13.52% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Guangdong Marubi Biotechnology Co and its competitors. This is near median its historical median of 14.71. Over the past decade, Guangdong Marubi Biotechnology Co's Return-on-Tangible-Equity has ranged from 7.32 to 36.27. According to the industry distribution chart, Guangdong Marubi Biotechnology Co ranks #970 out of 1882 companies in the Consumer Packaged Goods industry, placing it in the top 51.5%.
Is Guangdong Marubi Biotechnology Co's Return-on-Tangible-Equity too high?
Guangdong Marubi Biotechnology Co's current Return-on-Tangible-Equity of 13.52% is near median its 10-year median of 14.71. Over the past 10 years, this metric has ranged from a low of 7.32 to a high of 36.27. The Consumer Packaged Goods industry median Return-on-Tangible-Equity is 8.05. Guangdong Marubi Biotechnology Co's value of 13.52% is 68% above this industry median. Based on the distribution chart, Guangdong Marubi Biotechnology Co ranks #970 out of 1882 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Guangdong Marubi Biotechnology Co has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangdong Marubi Biotechnology Co's Return-on-Tangible-Equity compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Guangdong Marubi Biotechnology Co ranks #970 out of 1882 companies for Return-on-Tangible-Equity. This places Guangdong Marubi Biotechnology Co in the lower half of its industry. The industry median Return-on-Tangible-Equity is 8.05. Guangdong Marubi Biotechnology Co's value of 13.52% is 68% above this benchmark. Historically, Guangdong Marubi Biotechnology Co's own Return-on-Tangible-Equity has ranged from 7.32 to 36.27 over the past decade. While the company's 10-year median is 14.71 vs. the industry median of 8.05, Guangdong Marubi Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 8.05, based on 1,882 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangdong Marubi Biotechnology Co's current Return-on-Tangible-Equity of 13.52% is 68% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Guangdong Marubi Biotechnology Co and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Marubi Biotechnology Co's current Return-on-Tangible-Equity is 13.52%, which is near median its own 10-year median of 14.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Marubi Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Guangdong Marubi Biotechnology Co (SHSE:603983) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥43.76, compared to a current price of ¥30.20 — trading 31% below its estimated fair value. The current Return-on-Tangible-Equity is 13.52%, which is near median its 10-year median of 14.71 and 68% above the Consumer Packaged Goods industry median of 8.05. Guangdong Marubi Biotechnology Co's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Guangdong Marubi Biotechnology Co (SHSE:603983), the current Return-on-Tangible-Equity is 13.52% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangdong Marubi Biotechnology Co (SHSE:603983) Overvalued in 2026?
Based on GuruFocus' analysis, Guangdong Marubi Biotechnology Co stock appears to be undervalued.
The current stock price of ¥30.20 is trading 31% below its estimated GF Value™ of ¥43.76.
GuruFocus considers Guangdong Marubi Biotechnology Co to be Significantly Undervalued.
Key valuation signals for SHSE:603983:
Return-on-Tangible-Equity: 13.52% (near median its 10-year median of 14.71)
GF Value™: ¥43.76 vs. price of ¥30.20 (31% below fair value)
Industry Position: 68% above the Consumer Packaged Goods median (#970 of 1882)
No single metric tells the full story. See the SHSE:603983 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603983 has been successfully added to your 
